IMRA · Categories · Form 4

IMRA - SEC Form 4 insider transactions

IMARA Inc. (IMRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for IMRA

• 843d
  5am Partners Vi, Llc sold $12,292,500 worth of shares (825,000 units at $14.90) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Phillips Andrew John

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Patel Anish

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Lyssikatos Joseph P

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Kintz Samuel

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Hohl Benjamin

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Heyman Richard A.

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Gupta Rishi

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Derynck Mika K

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Collins Helen Louise

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Bauer Jake

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 844d
  SEC Form 4 filed by Ballal Rahul D.

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 851d
  Patel Anish sold $73,658 worth of shares (4,875 units at $15.11), decreasing direct ownership by 28% to 12,347 units (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 857d
  5am Partners Vi, Llc sold $7,500,000 worth of shares (500,000 units at $15.00) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 858d
  Heyman Richard A. sold $20,840 worth of shares (1,270 units at $16.41), decreasing direct ownership by 0.86% to 146,010 units (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 859d
  Lyssikatos Joseph P exercised 12,000 shares at a strike of $1.12 and sold $190,256 worth of shares (12,000 units at $15.85) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 859d
  Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $51,388 worth of shares (3,250 units at $15.81) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 861d
  Kintz Samuel exercised 12,000 shares at a strike of $1.12 and sold $188,229 worth of shares (12,000 units at $15.69) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 866d
  Patel Anish sold $73,783 worth of shares (4,875 units at $15.13), decreasing direct ownership by 22% to 17,222 units (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 887d
  Lyssikatos Joseph P exercised 12,000 shares at a strike of $1.12 and sold $171,381 worth of shares (12,000 units at $14.28) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 888d
  Patel Anish sold $203,348 worth of shares (13,540 units at $15.02), decreasing direct ownership by 38% to 22,097 units (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 888d
  Hohl Benjamin exercised 11,870 shares at a strike of $2.48 and sold $178,327 worth of shares (11,870 units at $15.02) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 893d
  Kintz Samuel exercised 12,000 shares at a strike of $1.12 and sold $175,709 worth of shares (12,000 units at $14.64) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 894d
  Patel Anish sold $16,306 worth of shares (1,085 units at $15.03), decreasing direct ownership by 3% to 35,637 units (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 894d
  Hohl Benjamin exercised 1,130 shares at a strike of $2.48 and sold $17,025 worth of shares (1,130 units at $15.07) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 895d
  Lyssikatos Joseph P exercised 6,566 shares at a strike of $1.12 and sold $85,790 worth of shares (6,566 units at $13.07) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 895d
  Kintz Samuel exercised 8,195 shares at a strike of $1.12 and sold $106,915 worth of shares (8,195 units at $13.05) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 895d
  Heyman Richard A. sold $2,808 worth of shares (216 units at $13.00), decreasing direct ownership by 0.12% to 147,280 units (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 900d
  Kintz Samuel exercised 7,779 shares at a strike of $1.12 and sold $101,238 worth of shares (7,779 units at $13.01) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 900d
  Lyssikatos Joseph P sold $115,646 worth of shares (8,888 units at $13.01) and exercised 8,888 shares at a strike of $1.12 (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 900d
  Heyman Richard A. sold $55,727 worth of shares (4,280 units at $13.02), decreasing direct ownership by 2% to 147,455 units (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 945d
  Lyssikatos Joseph P exercised 8,546 shares at a strike of $1.12 and sold $111,751 worth of shares (8,546 units at $13.08) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 945d
  Kintz Samuel sold $104,999 worth of shares (8,026 units at $13.08) and exercised 8,026 shares at a strike of $1.12 (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 979d
  Lyssikatos Joseph P exercised 12,000 shares at a strike of $1.12 and sold $163,498 worth of shares (12,000 units at $13.62) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 984d
  5am Partners Vi, Llc sold $2,962,500 worth of shares (197,500 units at $15.00) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 986d
  Kintz Samuel exercised 12,000 shares at a strike of $1.12 and sold $165,691 worth of shares (12,000 units at $13.81) (SEC Form 4)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1015d
  SEC Form 4: 5am Partners Vi, Llc sold $7,040,000 worth of shares (440,000 units at $16.00)

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1116d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1116d
  SEC Form 4 filed by Gupta Rishi

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Patel Anish

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Lyssikatos Joseph P

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Hohl Benjamin

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Collins Helen Louise

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Kintz Samuel

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Schwab Andrew J.

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Phillips Andrew John

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Heyman Richard A.

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Gupta Rishi

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Derynck Mika K

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Bauer Jake

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1159d
  SEC Form 4 filed by Ballal Rahul D.

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4: Schwab Andrew J. was granted 5,798,475 shares

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4: Heyman Richard A. was granted 218,399 shares

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4: Gupta Rishi was granted 7,899,572 shares

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4: Bauer Jake was granted 87,372 shares

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4 filed by Derynck Mika K

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4: Patel Anish was granted 430,749 shares

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4: Lyssikatos Joseph P was granted 1,117,035 shares

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4 filed by Hohl Benjamin

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
• 1197d
  SEC Form 4: Kintz Samuel was granted 1,264,587 shares

  4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)

Other IMRA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends